Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (61-70 of 320) with videos related to

Pageof 32
Sort By:
JAMA Network Open|February 9, 2022
Outcomes From Opportunistic Salpingectomy for Ovarian Cancer PreventionGillian E Hanley, Celeste Leigh Pearce, Aline Talhouk, et al.
Plos One|June 9, 2017
Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutationSatoshi Yanagida, Michael S Anglesio, Tayyebeh M Nazeran, et al.
Cancer Research|July 10, 2020
The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding SpecificityAnnaïck Carles, Genny Trigo-Gonzalez, Qi Cao, et al.
Genome Biology|February 7, 2013
DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancerAli Bashashati, Gholamreza Haffari, Jiarui Ding, et al.
Neoplasia (New York, N.Y.)|September 27, 2015
The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumorsYemin Wang, Jiamin Chen, Winnie Yang, et al.
Gynecologic Oncology|December 31, 2024
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer managementAndrea Neilson, Amy Jamieson, Derek Chiu, et al.
Breast Cancer Research and Treatment|April 14, 2007
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 casesAshish B Rajput, Dmitry A Turbin, Maggie Cu Cheang, et al.
Obstetrics and Gynecology|January 9, 2015
Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategyJanice S Kwon, Jessica N McAlpine, Gillian E Hanley, et al.
Familial Cancer|November 30, 2007
Hereditary diffuse gastric cancer: association with lobular breast cancerKasmintan A Schrader, Serena Masciari, Niki Boyd, et al.
Histopathology|October 14, 2014
Targeted mutation analysis of endometrial clear cell carcinomaLien N Hoang, Melissa K McConechy, Bo Meng, et al.
Pageof 32

Showing results (61-70 of 320) with videos related to

Sort By:
Pageof 32
JAMA Network Open|February 9, 2022
Outcomes From Opportunistic Salpingectomy for Ovarian Cancer PreventionGillian E Hanley, Celeste Leigh Pearce, Aline Talhouk, et al.
Plos One|June 9, 2017
Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutationSatoshi Yanagida, Michael S Anglesio, Tayyebeh M Nazeran, et al.
Cancer Research|July 10, 2020
The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding SpecificityAnnaïck Carles, Genny Trigo-Gonzalez, Qi Cao, et al.
Genome Biology|February 7, 2013
DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancerAli Bashashati, Gholamreza Haffari, Jiarui Ding, et al.
Neoplasia (New York, N.Y.)|September 27, 2015
The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumorsYemin Wang, Jiamin Chen, Winnie Yang, et al.
Gynecologic Oncology|December 31, 2024
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer managementAndrea Neilson, Amy Jamieson, Derek Chiu, et al.
Breast Cancer Research and Treatment|April 14, 2007
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 casesAshish B Rajput, Dmitry A Turbin, Maggie Cu Cheang, et al.
Obstetrics and Gynecology|January 9, 2015
Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategyJanice S Kwon, Jessica N McAlpine, Gillian E Hanley, et al.
Familial Cancer|November 30, 2007
Hereditary diffuse gastric cancer: association with lobular breast cancerKasmintan A Schrader, Serena Masciari, Niki Boyd, et al.
Histopathology|October 14, 2014
Targeted mutation analysis of endometrial clear cell carcinomaLien N Hoang, Melissa K McConechy, Bo Meng, et al.
Pageof 32